Hi!

While our field has its own regulatory, scientific, and stakeholder complexities, many of the judgment calls we face around trust, executive counsel, reputation, and change aren’t unique to biotech. Communicators in other highly scrutinized sectors often navigate similar pressures, often with lessons that translate in useful ways.

Tomorrow’s Comm Convo brings together communications leaders who have worked both inside and outside of biopharma. They’ll share how working in other industries can shape how we approach communications in the life sciences.

Comm Convo: The Outsider Advantage – Cross-Industry Comms Insights

📅 Thursday, March 26th, 12-1 p.m. ET / 9-10 a.m. PT / 4-5 p.m. GMT

T2B Pro & Student members (complimentary): Log in to your account and access your promo code here.
T2B Basic members ($40): Register here.

We’ll explore how to:

• Apply cross-industry lessons when advising leaders in complex environments
• Build influence across functions and organizational cultures
• Strengthen team adaptability while operating within constraints
• Bring an outside perspective to evolving trust and stakeholder challenges

Featured speakers:

• Lilian Anekwe, Director of Global Digital Communications, GSK
• Alexandra Engel, Vice President, Corporate Communications, Axon
• Jason Kravitz, Head of External Relations, Duke Health
• Kathleen Noonan, VP, Head of Corporate Communications, ITM (Moderator)

Join us for a practical discussion on how perspectives from outside biotech can strengthen how we advise, influence, and lead.

See you there!

Lynnea